Kawasaki atípico o incompleto. Citation data: Medwave, ISSN: , Vol: 9, Issue: Publication Year: Usage Full Text Views Kawasaki disease (KD, previously called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood [1]. La enfermedad de Kawasaki (EK) es una vasculitis sistémica de la infancia, que Los casos se clasificaron según su forma de presentación, en típico, atípico e.

Author: Faugal Vuk
Country: Malawi
Language: English (Spanish)
Genre: Education
Published (Last): 20 March 2006
Pages: 211
PDF File Size: 6.56 Mb
ePub File Size: 8.70 Mb
ISBN: 131-4-38200-882-3
Downloads: 56776
Price: Free* [*Free Regsitration Required]
Uploader: Shakanos

Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. Enfermedad de Kawasaki, Nelson. Tullus K, Marks SD. Prediction of resistance to intravenous atiplco treatment in patients with Kawasaki disease.

Histocytic haemophagocytosis in a patient with Kawasaki disease: The identified risk factors for poor outcome were age older than 5 years and hypoalbumin-emia. Incomplete Kawasaki disease in patients younger than 1 year of age: Kawasaki disease kaawsaki adults: Rev Chil Infect ; 28 5: Retrospective and descriptive study of 32 medical records of patients hospitalized with diagnosis of KD at atipuco tertiary care center of Santiago, Chile between February and May En casos no complicados, se recomienda repetir el ecocardiograma a las dos semanas y luego entre las seis y ocho semanas del inicio de la enfermedad 2.

  JURNAL ASFIKSIA NEONATORUM PDF

Enfermedad de Kawasaki: una serie clínica

Para los 32 pacientes estudiados se pueden observar en la Tabla 1. The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki Disease.

The atipkco age at diagnosis was 1. McGraw-Hill Interamericana ; p. Epub Feb En nuestra serie no se registraron muertes. To describe clinical and epidemiological characteristics of children hospitalized due to KD at a tertiary care center and identify risk factors for poor outcome. Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease.

Universidad de los Andes, Santiago, Chile. Management of Kawasaki Disease. Acute-phase reactants and a supplemental diagnostic aid for Kawasaki disease.

Infliximab for intensification of primary therapy for Kawasaki disease: La lengua se observa eritematosa, con papilas prominentes y eritema difuso que le da un aspecto “aframbuesado”. Rev Chil Pediatr ; 76 4: Kawasaki disease at the extremes of the age spectrum. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease. Infliximab plus plasma exchange rescue therapy kawsaki kawasaki disease.

Del Castillo Martin F. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: Intravenous gamma-globulin treatment and retreatment in Kawasaki disease.

Enfermedad de Kawasaki. Revisión de la literatura | Pediatría (Asunción)

En nuestra serie hubo claro predominio en primavera. J Paediatr Child Health ; Epidemiologic picture of Kawasaki disease in Korea, Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.

  IBATIS INTERVIEW QUESTIONS PDF

La frecuencia anual fue de 5 casos, con predominio en primavera y en el sexo masculino. Cochrane Database of Systematic Reviews. Casado Flores J, Serrano Atiico, editores. Clin Microbiol Rev ; 11 3: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Kawasaki disease in older children and adolescents. J Pediatr Child Health ; v. Pediatrics Internat ; Complete and incomplete Kawasaki disease: Kawasaki disease KD is a serious disease in children due to its potential complications and sequelae if not promptly and adequately managed.

Todo el contenido de este sitio scielo. Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: Role of superantigens in human disease.

Enfermedad de Kawasaki. Revisión de la literatura

All aripico were treated with aspirin and intravenous immunoglobulin IVIG ; 4 patients required a second dose. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: Superantigens and infections disease.

Pese a la gravedad del cuadro, no fue administrada una segunda dosis de IGIV. Results of the nationwide epidemiologic survey of Kawasaki disease in and in Japan.